Regulated Information - Transparency Statement Leuven, Belgium, 26 April 2017 - Pursuant to Belgian transparency legislation (Law of 2 May 2007), ThromboGenics NV (Euronext Brussels: THR) received a transparency notification on 26 April 2017 from Mr Thomas M Clay and from Mr Landon T. Clay and controlled entities (East Hill Hedge Fund LLC, Monadnock Charitable Lead Annuity Trust, Clay Fellowships Charitable Trust and The Clay Mathematics Institute, Inc., or the `East Hill Management Company LLC). Thomas M. Clay notified that, on 24 April 2017, the ThromboGenics shares controlled by himself have increased to 2,790,494 shares, or 7.73% of the current 36,094,349 outstanding ThromboGenics...
|
